Pharmaceutical Technology interviews Sussex Research Laboratories Inc. CEO, Dr. Brady Clark, on the “Role of NMR and Mass Spectroscopy in Glycan Analysis.”

Pharmaceutical Technology recently interviewed Sussex Research scientists, including Dr. Brady Clark, on the role of Nuclear Magnetic Resonance Spectroscopy (NMR) and Mass Spectrometry (MS) in Glycan Synthesis and Analysis. Sussex Research is a well known specialist in carbohydrate synthesis and glycodesign with an established international reputation. As discussed in the interview, NMR and MS are vital to successful development of glycosylation in syntheses of carbohydrate-based molecules and glycans. While NMR analysis provides crucial structural information of synthesized glycans that cannot be determined in any other way, MS analysis confirms molecular weight of target synthons. In bioanalytical analyses, LC-MS/MS is ideal for quantitation of free sugars in biological matrices.

To read the full article, you are directed to PharmaTech.com (http://www.pharmtech.com/role-nmr-and-mass-spectroscopy-glycan-analysis).

Back to blog

About Sussex Research Laboratories Inc.

Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists.

  • Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

  • Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

  • Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

1 of 3